Zimmerli, D., Brambillasca, C. S., Talens, F., Bhin, J., Linstra, R., Romanens, L., . . . Jonkers, J. (2022). MYC promotes immune-suppression in triple-negative breast cancer via inhibition of interferon signaling. Nature communications, 13(1), 6579-18. https://doi.org/10.1038/s41467-022-34000-6
Citace podle Chicago (17th ed.)Zimmerli, Dario, et al. "MYC Promotes Immune-suppression in Triple-negative Breast Cancer via Inhibition of Interferon Signaling." Nature Communications 13, no. 1 (2022): 6579-18. https://doi.org/10.1038/s41467-022-34000-6.
Citace podle MLA (9th ed.)Zimmerli, Dario, et al. "MYC Promotes Immune-suppression in Triple-negative Breast Cancer via Inhibition of Interferon Signaling." Nature Communications, vol. 13, no. 1, 2022, pp. 6579-18, https://doi.org/10.1038/s41467-022-34000-6.